Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Imatinib + Paclitaxel in UPSC
NCT00506779Phase 2Terminated
- Sponsor
- University of Texas MD Anderson Cancer Center
- Start
- Dec 2003
- Primary completion
- Apr 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of imatinib in uterine papillary serous carcinoma (UPSC), sponsored by University of Texas MD Anderson Cancer Center. Started Dec 2003; status: terminated.
02
Drugs
03
Conditions
uterine papillary serous carcinoma (UPSC)
Beyond the preview
Go deeper on NCT00506779.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00506779.